Stock Markets September 9, 2026 07:45 AM

Dow Weighs Selling Its 35% Stake in $20 Billion Sadara Chemicals Venture

Move reflects portfolio restructuring amid a prolonged chemicals industry downturn; Aramco could buy the holding or outside bidders may emerge

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
DOW

Dow Inc. is considering options to divest its 35% stake in the $20 billion Sadara Chemical Co. joint venture with Saudi Aramco, according to Bloomberg News. The deliberations form part of Dow's portfolio reshaping in the face of an extended downturn in the chemicals sector. No final decision has been made, and discussions remain confidential.

Dow Weighs Selling Its 35% Stake in $20 Billion Sadara Chemicals Venture
DOW
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Dow is reportedly evaluating an exit from its 35% stake in the $20 billion Sadara Chemical Co. joint venture with Saudi Aramco.
  • Saudi Aramco could potentially purchase Dow's stake to increase its ownership; alternatively, strategic or financial investors may bid.
  • No final decision has been taken and discussions are confidential - the company could decide not to pursue a transaction.

Summary: Dow Inc. is exploring potential paths to exit its interest in a $20 billion chemicals joint venture with Saudi Aramco, Bloomberg News reported, citing people familiar with the matter. The deliberations are part of the U.S. company's efforts to reshape its portfolio amid an extended downturn in the chemicals industry.

According to the report, Dow held a 35% stake in the venture, Sadara Chemical Co., as of last year. Saudi Aramco owns the remaining interest in the partnership. The people Bloomberg spoke to said Aramco could use the opportunity to buy Dow's shares and thereby increase its ownership in the venture.

The report also indicated that other parties - described as potential strategic or financial investors - could submit bids for Dow's holding. At this stage, no final determinations have been reached and the company could ultimately elect not to move forward with a sale or other transaction, the people said.

Those familiar with the discussions declined to be identified, the report added, citing the confidential nature of the talks. The coverage framed the deliberations as one element of Dow's wider attempts to reorganize its assets during a prolonged slump across the chemicals sector.

The facts reported are limited to the points above: the 35% stake held by Dow as of last year in Sadara Chemical Co.; the venture's $20 billion valuation; Aramco's ownership of the remainder of the partnership; the possibility that Aramco or other strategic or financial bidders could acquire Dow's position; and the absence of any final decision, with discussions remaining confidential.


Context and next steps: The information available publicly is confined to the reporting noted here. It does not indicate a completed transaction, a timetable for any potential sale, or the identity of any prospective bidders beyond the general categories mentioned. Dow's consideration of options and the confidential status of the conversations mean outcomes remain uncertain until the company makes any formal announcement.

Risks

  • No transaction certainty - Dow may choose not to sell its stake, leaving ownership unchanged; impacts corporate strategy and investor expectations (affects chemicals sector and equity markets).
  • Confidential talks - limited public information increases uncertainty around timing, pricing and potential buyers (affects capital markets and deal-making activity).
  • Potential shift in ownership - if Aramco increases its stake or a new investor enters, governance and strategic direction at Sadara could change (affects the chemicals sector and related industrial supply chains).

More from Stock Markets

BofA Sees Apollo’s easyJet Bid Sparking Consolidation That Favors Scarce Airline Assets Sep 9, 2026 Covenant launches Saxony production hub for Anthem cruise missile Sep 9, 2026 Amazon to Raise £4 Billion in First Sterling Bond Issue as Demand Surges Sep 9, 2026 J.P. Morgan Flags Caution for European Medtech, Sees Hearing-Aid Demand Leading Recovery Sep 9, 2026 Barclays Raises S&P 500 Target, Citing Strong Q2 Earnings Led by Technology Sep 9, 2026